A Pilot Study of Berberine (Soloways ™) in Patients with Type 2 Diabetes Mellitus Carrying TCF7L2 Polymorphisms

Clinical trial NCT06863922 · COMPLETED

Trial details

NCT number: NCT06863922
Sponsor: S.LAB (SOLOWAYS)
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2024-05-03
Primary completion: 2024-08-14
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.